Salvage endoscopic nasopharyngectomy and intensity-modulated radiotherapy versus conventional radiotherapy in treating locally recurrent nasopharyngeal carcinoma

Head and Neck

Volumn 37, Issue 8, 2015, Pages 1108-1115

  Zou, Xiong ^a   Han, Fei ^a   Ma, Wen Juan ^a   Deng, Man Quan ^a   Jiang, Rou ^a   Guo, Ling ^a   Liu, Qing ^a   Mai, Hai Qiang ^a   Hong, Ming Huang ^a   Chen, Ming Yuan ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

endoscopic nasopharyngectomy; intensity modulated radiotherapy (IMRT); nasopharyngeal carcinoma; recurrence

Indexed keywords

CISPLATIN;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DISTANT METASTASIS FREE SURVIVAL; EAR NOSE THROAT SURGERY; ENDOSCOPIC NASOPHARYNGECTOMY; ENDOSCOPIC SURGERY; FEMALE; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LOCAL RECURRENCE FREE SURVIVAL; MALE; MICROWAVE THERAPY; MULTILEAF COLLIMATOR; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; RECURRENT DISEASE; SALVAGE THERAPY; THERAPY EFFECT; ADJUVANT CHEMOTHERAPY; CHINA; COMPARATIVE STUDY; CONFORMAL RADIOTHERAPY; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NATURAL ORIFICE TRANSLUMINAL ENDOSCOPIC SURGERY; NOSE; PROCEDURES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; CHEMOTHERAPY, ADJUVANT; CHINA; FEMALE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NATURAL ORIFICE ENDOSCOPIC SURGERY; NEOPLASM RECURRENCE, LOCAL; NOSE; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; SALVAGE THERAPY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84948563999     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23719     Document Type: Article

References (28)

1. Lai SZ, Li WF, Chen L, et al., How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients? Int J Radiat Oncol Biol Phys 2011; 80: 661-668.
2. Xiao WW, Huang SM, Han F, et al., Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy: long-term results of a phase 2 study. Cancer 2011; 117: 1874-1883.
3. Yu KH, Leung SF, Tung SY, et al., Survival outcome of patients with nasopharyngeal carcinoma with first local failure: a study by the Hong Kong Nasopharyngeal Carcinoma Study Group. Head Neck 2005; 27: 397-405.
4. Chen MY, Wen WP, Guo X, et al., Endoscopic nasopharyngectomy for locally recurrent nasopharyngeal carcinoma. Laryngoscope 2009; 119: 516-522.
5. Mai HQ, Mo HY, Deng JF, et al., Endoscopic microwave coagulation therapy for early recurrent T1 nasopharyngeal carcinoma. Eur J Cancer 2009; 45: 1107-1110.
6. Chan JY, Wei WI,. Recurrent nasopharyngeal carcinoma after salvage nasopharyngectomy. Arch Otolaryngol Head Neck Surg 2012; 138: 572-576.
7. Hua YJ, Han F, Lu LX, et al., Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy. Eur J Cancer 2012; 48: 3422-3428.
8. Han F, Zhao C, Huang SM, et al., Long-term outcomes and prognostic factors of re-irradiation for locally recurrent nasopharyngeal carcinoma using intensity-modulated radiotherapy. Clin Oncol (R Coll Radiol) 2012; 24: 569-576.
9. Qiu S, Lin S, Tham IW, Pan J, Lu J, Lu JJ,. Intensity-modulated radiation therapy in the salvage of locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2012; 83: 676-683.
10. Lee AW, Foo W, Law SC, et al., Total biological effect on late reactive tissues following reirradiation for recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2000; 46: 865-872.
11. Oksüz DC, Meral G, Uzel O, Caʇatay P, Turkan S,. Reirradiation for locally recurrent nasopharyngeal carcinoma: treatment results and prognostic factors. Int J Radiat Oncol Biol Phys 2004; 60: 388-394.
12. Chang JT, See LC, Liao CT, et al., Locally recurrent nasopharyngeal carcinoma. Radiother Oncol 2000; 54: 135-142.
13. Wei WI, Chan JY, Ng RW, Ho WK,. Surgical salvage of persistent or recurrent nasopharyngeal carcinoma with maxillary swing approach-critical appraisal after 2 decades. Head Neck 2011; 33: 969-975.
14. Chen MY, Cao XP, Sun R, et al., Application of interstitial brachytherapy via parapharynx involvement transnasal approach to enhance dose in radiotherapy for nasopharyngeal carcinoma [in Chinese]. Ai Zheng 2007; 26: 513-518.
15. Cao X, Chen K, He Z,. Short- and long-term therapeutic effects of brachytherapy on intracavitary residual tumor in 563 nasopharyngeal carcinoma (NPC) patients [in Chinese]. Zhonghua Zhong Liu Za Zhi 1998; 20: 146-147.
16. Lu TX, Mai WY, Teh BS, et al., Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2004; 58: 682-687.
17. Chen MY, Hua YJ, Wan XB, et al., A posteriorly pedicled middle turbinate mucoperiosteal flap resurfacing nasopharynx after endoscopic nasopharyngectomy for recurrent nasopharyngeal carcinoma. Otolaryngol Head Neck Surg 2012; 146: 409-411.
18. Chen MY, Wang SL, Zhu YL, et al., Use of a posterior pedicle nasal septum and floor mucoperiosteum flap to resurface the nasopharynx after endoscopic nasopharyngectomy for recurrent nasopharyngeal carcinoma. Head Neck 2012; 34: 1383-1388.
19. Ma BB, Tannock IF, Pond GR, Edmonds MR, Siu LL,. Chemotherapy with gemcitabine-containing regimens for locally recurrent or metastatic nasopharyngeal carcinoma. Cancer 2002; 95: 2516-2523.
20. Chua DT, Sham JS, Au GK,. A phase II study of capecitabine in patients with recurrent and metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy. Oral Oncol 2003; 39: 361-366.
21. You B, Le Tourneau C, Chen EX, et al., A phase II trial of erlotinib as maintenance treatment after gemcitabine plus platinum-based chemotherapy in patients with recurrent and/or metastatic nasopharyngeal carcinoma. Am J Clin Oncol 2012; 35: 255-260.
22. Syed AM, Puthawala AA, Damore SJ, et al., Brachytherapy for primary and recurrent nasopharyngeal carcinoma: 20 years' experience at Long Beach Memorial. Int J Radiat Oncol Biol Phys 2000; 47: 1311-1321.
23. Wu SX, Chua DT, Deng ML, et al., Outcome of fractionated stereotactic radiotherapy for 90 patients with locally persistent and recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2007; 69: 761-769.
24. Seo Y, Yoo H, Yoo S, et al., Robotic system-based fractionated stereotactic radiotherapy in locally recurrent nasopharyngeal carcinoma. Radiother Oncol 2009; 93: 570-574.
25. Zheng XK, Ma J, Chen LH, Xia YF, Shi YS,. Dosimetric and clinical results of three-dimensional conformal radiotherapy for locally recurrent nasopharyngeal carcinoma. Radiother Oncol 2005; 75: 197-203.
26. Ozyigit G, Cengiz M, Yazici G, et al., A retrospective comparison of robotic stereotactic body radiotherapy and three-dimensional conformal radiotherapy for the reirradiation of locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2011; 81: e263-e268.
27. Chan YW, Chow VL, Wei WI,. Quality of life of patients after salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma. Cancer 2012; 118: 3710-3718.
28. King WW, Ku PK, Mok CO, Teo PM,. Nasopharyngectomy in the treatment of recurrent nasopharyngeal carcinoma: a twelve-year experience. Head Neck 2000; 22: 215-222.